BioCentury | Feb 4, 2021
Deals

Feb. 3 Quick Takes: Hillhouse takes stakes in InnoCare, Luye; plus Merck KGaA, Inivata, Reverie, Neurocrine, Eisai and more

...as did existing investor IP Group.Next-gen kinase company Reverie raises $25MComputational kinase drug discovery company Reverie Labs Inc....
...and is eligible for research, development and regulatory milestones, plus royalties. BC Staff Tepmetko (tepotinib, MSC2156119J) Hillhouse Capital Merck KGaA Reverie Labs Inc. Neurocrine...
Items per page:
1 - 1 of 1
BioCentury | Feb 4, 2021
Deals

Feb. 3 Quick Takes: Hillhouse takes stakes in InnoCare, Luye; plus Merck KGaA, Inivata, Reverie, Neurocrine, Eisai and more

...as did existing investor IP Group.Next-gen kinase company Reverie raises $25MComputational kinase drug discovery company Reverie Labs Inc....
...and is eligible for research, development and regulatory milestones, plus royalties. BC Staff Tepmetko (tepotinib, MSC2156119J) Hillhouse Capital Merck KGaA Reverie Labs Inc. Neurocrine...
Items per page:
1 - 1 of 1